NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive: However, the addition of ADR showed that Nrf2 knockdown resulted in a significantly augmented chemotherapy-induced reduction in colony formation in the high-Nrf2 expressing resistant CML cells (Fig. 6B).